Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 107

    2.

    Optimizing the therapeutic index of liposomal glucocorticoids in experimental arthritis.

    van den Hoven JM, Hofkens W, Wauben MH, Wagenaar-Hilbers JP, Beijnen JH, Nuijen B, Metselaar JM, Storm G.

    Int J Pharm. 2011 Sep 20;416(2):471-7. Epub 2011 Apr 2.

    PMID:
    21440612
    [PubMed - indexed for MEDLINE]
    3.

    Complete remission of experimental arthritis by joint targeting of glucocorticoids with long-circulating liposomes.

    Metselaar JM, Wauben MH, Wagenaar-Hilbers JP, Boerman OC, Storm G.

    Arthritis Rheum. 2003 Jul;48(7):2059-66.

    PMID:
    12847701
    [PubMed - indexed for MEDLINE]
    Free Article
    4.

    Liposomal targeting of glucocorticoids to synovial lining cells strongly increases therapeutic benefit in collagen type II arthritis.

    Metselaar JM, van den Berg WB, Holthuysen AE, Wauben MH, Storm G, van Lent PL.

    Ann Rheum Dis. 2004 Apr;63(4):348-53.

    PMID:
    15020326
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    5.

    Neonatal dexamethasone and chronic tianeptine treatment inhibit ligature-induced periodontitis in adult rats.

    Breivik T, Gundersen Y, Osmundsen H, Fonnum F, Opstad PK.

    J Periodontal Res. 2006 Feb;41(1):23-32.

    PMID:
    16409252
    [PubMed - indexed for MEDLINE]
    6.

    Long-circulating liposomes for i.v. targeted delivery of glucocorticoids in arthritis.

    Metselaar JM, Wauben MH, Boerman OC, Van Lent PL, Storm G.

    Cell Mol Biol Lett. 2002;7(2):291-2. No abstract available.

    PMID:
    12097962
    [PubMed - indexed for MEDLINE]
    7.

    Liposomal encapsulation enhances and prolongs the anti-inflammatory effects of water-soluble dexamethasone phosphate in experimental adjuvant arthritis.

    Anderson R, Franch A, Castell M, Perez-Cano FJ, Bräuer R, Pohlers D, Gajda M, Siskos AP, Katsila T, Tamvakopoulos C, Rauchhaus U, Panzner S, Kinne RW.

    Arthritis Res Ther. 2010;12(4):R147. Epub 2010 Jul 19.

    PMID:
    20642832
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    8.

    Effects of glucocorticoids on the hypothalamic-pituitary-adrenal axis in children and adults.

    Gulliver T, Eid N.

    Immunol Allergy Clin North Am. 2005 Aug;25(3):541-55, vii. Review.

    PMID:
    16054542
    [PubMed - indexed for MEDLINE]
    9.

    Novel dexamethasone-HPMA copolymer conjugate and its potential application in treatment of rheumatoid arthritis.

    Wang D, Miller SC, Liu XM, Anderson B, Wang XS, Goldring SR.

    Arthritis Res Ther. 2007;9(1):R2.

    PMID:
    17233911
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    10.

    A plant-derived glucocorticoid receptor modulator attenuates inflammation without provoking ligand-induced resistance.

    Gossye V, Elewaut D, Van Beneden K, Dewint P, Haegeman G, De Bosscher K.

    Ann Rheum Dis. 2010 Jan;69(1):291-6. Epub .

    PMID:
    19204014
    [PubMed - indexed for MEDLINE]
    11.

    Long-term effects of neonatal hydrocortisone treatment for chronic lung disease on the developing brain and heart.

    Rademaker KJ, de Vries WB.

    Semin Fetal Neonatal Med. 2009 Jun;14(3):171-7. Epub 2008 Dec 19. Review.

    PMID:
    19101215
    [PubMed - indexed for MEDLINE]
    12.

    Pharmacokinetics of dexamethasone in a rat model of rheumatoid arthritis.

    Earp JC, Pyszczynski NA, Molano DS, Jusko WJ.

    Biopharm Drug Dispos. 2008 Sep;29(6):366-72.

    PMID:
    18613033
    [PubMed - indexed for MEDLINE]
    14.

    Hypothalamic-pituitary-adrenal-glucocorticoid axis function in rheumatoid arthritis.

    Masi AT, Chrousos GP.

    J Rheumatol. 1996 Apr;23(4):577-81. Review. No abstract available.

    PMID:
    8730107
    [PubMed - indexed for MEDLINE]
    15.

    Effect of a novel anti-rheumatic drug, TA-383, on type II collagen-induced arthritis.

    Ueno M, Imaizumi K, Sugita T, Takata I, Takeshita M.

    Int J Immunopharmacol. 1995 Jul;17(7):597-603.

    PMID:
    8586488
    [PubMed - indexed for MEDLINE]
    16.

    Evidence for ototopical glucocorticoid-induced decrease in hypothalamic-pituitary-adrenal axis response and liver function.

    Abraham G, Gottschalk J, Ungemach FR.

    Endocrinology. 2005 Jul;146(7):3163-71. Epub 2005 Mar 31.

    PMID:
    15802495
    [PubMed - indexed for MEDLINE]
    Free Article
    17.

    Targeted delivery of liposomal dexamethasone phosphate to the spleen provides a persistent therapeutic effect in rat antigen-induced arthritis.

    Rauchhaus U, Kinne RW, Pohlers D, Wiegand S, Wölfert A, Gajda M, Bräuer R, Panzner S.

    Ann Rheum Dis. 2009 Dec;68(12):1933-4. No abstract available.

    PMID:
    19910302
    [PubMed - indexed for MEDLINE]
    18.

    Effects of dermal dexamethasone application on ACTH and both basal and ACTH-stimulated cortisol concentration in normal horses.

    Abraham G, Allersmeier M, Gottschalk J, Schusser GF, Hoppen HO, Ungemach FR.

    J Vet Pharmacol Ther. 2009 Aug;32(4):379-87.

    PMID:
    19614843
    [PubMed - indexed for MEDLINE]
    19.

    Safety of glucocorticoids can be improved by lower yet still effective dosages of liposomal steroid formulations in murine antigen-induced arthritis: comparison of prednisolone with budesonide.

    Hofkens W, van den Hoven JM, Pesman GJ, Nabbe KC, Sweep FC, Storm G, van den Berg WB, van Lent PL.

    Int J Pharm. 2011 Sep 20;416(2):493-8. Epub 2011 Mar 4.

    PMID:
    21382459
    [PubMed - indexed for MEDLINE]
    20.

    Suppression and recovery of the neonatal hypothalamic-pituitary-adrenal axis after prolonged dexamethasone therapy.

    Ford LR, Willi SM, Hollis BW, Wright NM.

    J Pediatr. 1997 Nov;131(5):722-6.

    PMID:
    9403653
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk